- Home
- RLMD vs BNGO Comparison
RLMD vs BNGO Comparison
Compare RLMD & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- BNGO
- Stock Information
- Founded
- RLMD 2004
- BNGO 2003
- Country
- RLMD United States
- BNGO United States
- Employees
- RLMD N/A
- BNGO N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- RLMD Health Care
- BNGO Industrials
- Exchange
- RLMD Nasdaq
- BNGO Nasdaq
- Market Cap
- RLMD 22.0M
- BNGO 24.3M
- IPO Year
- RLMD N/A
- BNGO 2018
- Fundamental
- Price
- RLMD $0.83
- BNGO $3.75
- Analyst Decision
- RLMD Hold
- BNGO Buy
- Analyst Count
- RLMD 4
- BNGO 5
- Target Price
- RLMD $4.25
- BNGO $7.33
- AVG Volume (30 Days)
- RLMD 840.1K
- BNGO 136.4K
- Earning Date
- RLMD 05-12-2025
- BNGO 05-14-2025
- Dividend Yield
- RLMD N/A
- BNGO N/A
- EPS Growth
- RLMD N/A
- BNGO N/A
- EPS
- RLMD N/A
- BNGO N/A
- Revenue
- RLMD N/A
- BNGO $28,464,000.00
- Revenue This Year
- RLMD N/A
- BNGO $1.79
- Revenue Next Year
- RLMD N/A
- BNGO $14.90
- P/E Ratio
- RLMD N/A
- BNGO N/A
- Revenue Growth
- RLMD N/A
- BNGO N/A
- 52 Week Low
- RLMD $0.24
- BNGO $2.68
- 52 Week High
- RLMD $4.47
- BNGO $56.01
- Technical
- Relative Strength Index (RSI)
- RLMD 72.41
- BNGO 48.53
- Support Level
- RLMD $0.65
- BNGO $3.57
- Resistance Level
- RLMD $0.77
- BNGO $3.88
- Average True Range (ATR)
- RLMD 0.10
- BNGO 0.18
- MACD
- RLMD 0.02
- BNGO 0.00
- Stochastic Oscillator
- RLMD 86.00
- BNGO 61.82
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.